Diagnosing narcolepsy with cataplexy on history alone: Challenging the International Classification of Sleep Disorders (ICSD-2) criteria

European Journal of Neurology

Volumn 18, Issue 7, 2011, Pages 1017-1020

  Morrison, I ^a   Buskova J ^b   Nevsimalova S ^b   Douglas, N J ^c   Riha, R L ^c  

^a INSTITUTE OF NEUROLOGICAL SCIENCES   (United Kingdom)

^b CHARLES UNIVERSITY   (Czech Republic)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Cataplexy; Multiple sleep latency testing; Narcolepsy; Pseudonarcolepsy; Somatoform disorders

Indexed keywords

AMPHETAMINE; CABERGOLINE; CITALOPRAM; CLOMIPRAMINE; CLONAZEPAM; ESOMEPRAZOLE; ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE; INSULIN; SIMVASTATIN;

ADULT; ARTICLE; CATAPLEXY; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; HUMAN; INTERNATIONAL CLASSIFICATION OF SLEEP DISORDER 2; MEDICAL HISTORY; MULTIPLE SLEEP LATENCY TESTING; NARCOLEPSY; POLYSOMNOGRAPHY; PRIORITY JOURNAL; SLEEP PARAMETERS;

ADULT; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MEDICAL HISTORY TAKING; MIDDLE AGED; NARCOLEPSY; POLYSOMNOGRAPHY;

EID: 79958863775     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2010.03223.x     Document Type: Article

References (17)

1. Longstreth WTJ, Koepsell TD, Ton TG, Hendrickson AF, van Belle G. The epidemiology of narcolepsy. Sleep 2007; 30: 13-26.
2. Douglas NJ. The psychosocial aspects of narcolepsy. Neurology 1998; 50: S27-S30.
3. Billiard M. Diagnosis of narcolepsy and idiopathic hypersomnia. An update based on the International classification of sleep disorders, 2nd edition. Sleep Med Rev 2007; 11: 377-388.
4. Krahn LE. Reevaluating spells initially identified as cataplexy. Sleep Med 2005; 6: 537-542.
5. Krahn LE, Hansen MR, Shepard JW. Pseudocataplexy. Psychosomatics 2001; 42: 356-358.
6. Krahn LE, Gonzalez-Arriaza HL. Narcolepsy with cataplexy. Am J Psychiatry 2004; 161: 2181-2184.
7. Hicks JA, Shapiro CM. Pseudo-narcolepsy: case report. J Psychiatry Neurosci 1999; 24: 348-350.
8. Billiard M, Bassetti C, Dauvilliers Y, et al. EFNS Task Force. EFNS guidelines on management of narcolepsy. Eur J Neurol 2006; 13: 1035-1048.
9. Thorpy MJ. Cataplexy associated with narcolepsy: epidemiology, pathophysiology and management. CNS Drugs 2006; 20: 43-50.
10. Krahn LE, Gozalez-Arriaza HL. The multiple sleep latency test in the diagnosis of narcolepsy. Am J Psychiatry 2005; 162: 2199.
11. Anic-Labat S, Guilleminault C, Kraemer HC, Meehan J, Arrigoni J, Mignot E. Validation of a cataplexy questionnaire in 983 sleep-disorders patients. Sleep 1999; 22: 77-87.
12. British National Formulary. 2007
13. Kushida CA, Littner MR, Morgenthaler T, et al. Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep 2005; 28: 499-521.
14. Littner MR, Kushida C, Wise M, et al. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep 2005; 28: 113-121.
15. Arand D, Bonnet M, Hurwitz T, Mitler M, Rosa R, Sangal RB. The clinical use of the MSLT and MWT. Sleep 2005; 28: 123-144.
16. Knudsen S, Jennum PJ, Alving J, Sheikh SP, Gammeltoft S. Validation of the ICSD-2 criteria for CSF hypocretin-1 measurements in the diagnosis of narcolepsy in the Danish population. Sleep 2010; 33: 169-176.
17. Zeman A, Britton T, Douglas N, et al. Narcolepsy and excessive daytime sleepiness. BMJ 2004; 329: 724-728.